AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Shipping giant MSC submits bid for ZIM, challenging Hapag-Lloyd in takeover race
2
“Younger people are getting cancer more and more. We have to make kinder medicines.”
3
ServiceNow in advanced talks to acquire Armis at around $7 billion valuation
4
Armis sale to ServiceNow could yield $4 billion windfall for Insight Partners
5
Starlink selects Israeli chipmaker Xsight for V3 satellite network
More news

Polypid

6 stories about Polypid
מוסף ניתוח מנתחים רופא רופאים חדר ניתוח

Biotech Company Polypid Raises $15 Million

07.11.18|Lilach Baumer
Israel-based Polypid develops encapsulating drug delivery technology that enables extended and localized release in the body
אמיר וייסברג

CTech’s Sunday Roundup of Israeli Tech News

25.03.18|CTech
U.S. court charges Israeli CEO with binary options fraud. Stock market downturn leads biotech company Polypid to backtrack on IPO
חיים הורביץ איש עסקים דירקטור ב חברת טבע

Stock Market Downturn Leads Biotech Company Polypid to Backtrack on IPO

25.03.18|Dror Reich
The Israel-based company has postponed its planned IPO after Nasdaq, Dow Jones trended down heavily last week
אלביט מערכות נתנאל גרופ פארק תמר רחובות

CTech’s Thursday Israeli Tech News Roundup

15.03.18|CTech
Israel-based defense and homeland security manufacturer and contractor Elbit wins a $65 million contract with an unnamed Asian-Pacific country. In protest of new bonus plan, Teva sued by Israeli employees
נאסדק נאסד"ק ניו יורק בורסה בועה

Biotech Company Polypid Aims to Raise $75 Million with Nasdaq IPO

15.03.18|Dror Reich
The Israel-based company develops a pharmaceutical mechanism that slows down drug delivery
אמיר וייסברג

Controlled Drug Release Company Polypid Attempts Second Nasdaq IPO

11.02.18|Dror Reich
The Israel-based company is looking to raise up to $86.25 million to fund clinical development and trials and manufacturing activities